The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2022 | BTOG 2022 highlights: Prehabilitation and psycho-oncology
Samreen Ahmed, FRCP, MD, University Hospitals of Leicester, Leicester, UK, gives her highlights during the 20th Annual British Thoracic Oncology Group (BTOG) Conference, including symposia relating to the quality of life of patients during a cancer diagnosis, as well as the psychological impact of treatment. Prof. Ahmed also mentions sessions relating to prehabilitation and the latest updates in operable non-small cell lung cancer. This interview took place at the 20th BTOG Conference 2022.
